{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:16:56Z","timestamp":1790626616493,"version":"4.1.0"},"reference-count":89,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.25531","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T15:39:13Z","timestamp":1632497953000},"page":"e2125531","source":"Crossref","is-referenced-by-count":121,"title":["Magnitude of the Placebo Response Across Treatment Modalities Used for Treatment-Resistant Depression in Adults"],"prefix":"10.1001","volume":"4","author":[{"given":"Brett D. M.","family":"Jones","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lais B.","family":"Razza","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil"},{"name":"Laboratory of Neurosciences, Instituto Nacional de Biomarcadores em Neuropsiquiatria, Department and Institute of Psychiatry, Faculdade de Medicina, University of Sao Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory R.","family":"Weissman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jewel","family":"Karbi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tya","family":"Vine","sequence":"additional","affiliation":[{"name":"Michael G. Degroote School of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise S.","family":"Mulsant","sequence":"additional","affiliation":[{"name":"Nova Scotia Health, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre R.","family":"Brunoni","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil"},{"name":"Laboratory of Neurosciences, Instituto Nacional de Biomarcadores em Neuropsiquiatria, Department and Institute of Psychiatry, Faculdade de Medicina, University of Sao Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Ishrat","family":"Husain","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit H.","family":"Mulsant","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Blumberger","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafiris J.","family":"Daskalakis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"issue":"8","key":"zoi210753r1","first-page":"627","article-title":"STAR*D: revising conventional wisdom.","volume":"23","author":"Rush","year":"2009","journal-title":"CNS Drugs"},{"key":"zoi210753r2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jad.2018.06.045","article-title":"The burden of treatment-resistant depression: a systematic review of the economic and quality of life literature.","volume":"242","author":"Johnston","year":"2019","journal-title":"J Affect Disord"},{"issue":"5","key":"zoi210753r3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2174\/1570159X13666150630174343","article-title":"From randomized controlled trials of antidepressant drugs to the meta-analytic synthesis of evidence: methodological aspects lead to discrepant findings.","volume":"13","author":"Fountoulakis","year":"2015","journal-title":"Curr Neuropharmacol"},{"issue":"14","key":"zoi210753r4","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1001\/jama.287.14.1840","article-title":"Placebo response in studies of major depression: variable, substantial, and growing.","volume":"287","author":"Walsh","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"zoi210753r5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1755-5949.2010.00151.x","article-title":"Why has the antidepressant-placebo difference in antidepressant clinical trials diminished over the past three decades?","volume":"16","author":"Khan","year":"2010","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"zoi210753r6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4088\/JCP.08r04516blu","article-title":"Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.","volume":"71","author":"Sinyor","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"zoi210753r7","doi-asserted-by":"publisher","first-page":"676","DOI":"10.4088\/JCP.11r06978","article-title":"Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation\/combination strategies in treatment partial responders\/nonresponders with major depressive disorder?","volume":"73","author":"Iovieno","year":"2012","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"zoi210753r8","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/sj.npp.1300059","article-title":"Frequency of positive studies among fixed and flexible dose antidepressant clinical trials: an analysis of the food and drug administration summary basis of approval reports.","volume":"28","author":"Khan","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"zoi210753r9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.0006-341X.2000.00271.x","article-title":"The impact of restrictive entry criterion during the placebo lead-in period.","volume":"56","author":"Landin","year":"2000","journal-title":"Biometrics"},{"issue":"7","key":"zoi210753r10","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4088\/JCP.12r08267","article-title":"Less is more in antidepressant clinical trials: a meta-analysis of the effect of visit frequency on treatment response and dropout.","volume":"74","author":"Rutherford","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"7-08","key":"zoi210753r11","first-page":"12","article-title":"Is high placebo response really a problem in depression trials? a critical re-analysis of depression studies.","volume":"16","author":"Whitlock","year":"2019","journal-title":"Innov Clin Neurosci"},{"key":"zoi210753r12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jpsychires.2019.11.014","article-title":"Early score fluctuation and placebo response in a study of major depressive disorder.","volume":"121","author":"Targum","year":"2020","journal-title":"J Psychiatr Res"},{"issue":"11","key":"zoi210753r13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S2215-0366(16)30307-8","article-title":"Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies.","volume":"3","author":"Furukawa","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"zoi210753r14","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110261","article-title":"Determinants of sham response in tDCS depression trials: a systematic review and meta-analysis.","volume":"109","author":"De Smet","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"zoi210753r15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pnpbp.2017.10.016","article-title":"A systematic review and meta-analysis on placebo response to repetitive transcranial magnetic stimulation for depression trials.","volume":"81","author":"Razza","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"zoi210753r16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004824","article-title":"Placebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysis.","volume":"4","author":"Brunoni","year":"2009","journal-title":"PLoS One"},{"key":"zoi210753r17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.psychres.2018.07.020","article-title":"Cognitive behavioral therapy for treatment-resistant depression: a systematic review and meta-analysis.","volume":"268","author":"Li","year":"2018","journal-title":"Psychiatry Res"},{"key":"zoi210753r18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jad.2020.09.007","article-title":"A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009-January 2019.","volume":"277","author":"Marcantoni","year":"2020","journal-title":"J Affect Disord"},{"key":"zoi210753r19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jad.2021.03.019","article-title":"Comparative efficacy and acceptability of neuromodulation procedures in the treatment of treatment-resistant depression: a network meta-analysis of randomized controlled trials.","volume":"287","author":"Li","year":"2021","journal-title":"J Affect Disord"},{"key":"zoi210753r20","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jad.2020.06.050","article-title":"The effect of intravenous, intranasal, and oral ketamine in mood disorders: a meta-analysis.","volume":"276","author":"McIntyre","year":"2020","journal-title":"J Affect Disord"},{"issue":"5-6","key":"zoi210753r21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/09540261.2020.1765748","article-title":"Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysis.","volume":"32","author":"Carter","year":"2020","journal-title":"Int Rev Psychiatry"},{"issue":"2","key":"zoi210753r22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041349","article-title":"Protocol for a systematic review and meta-analysis of the placebo response in treatment-resistant depression: comparison of multiple treatment modalities.","volume":"11","author":"Jones","year":"2021","journal-title":"BMJ Open"},{"key":"zoi210753r23","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.h1793","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"issue":"7829","key":"zoi210753r27","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"zoi210753r28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.neubiorev.2018.05.015","article-title":"Efficacy and acceptability of non-invasive brain stimulation for the treatment of adult unipolar and bipolar depression: a systematic review and meta-analysis of randomised sham-controlled trials.","volume":"92","author":"Mutz","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"issue":"7414","key":"zoi210753r30","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"zoi210753r31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.5455\/bcp.20120807092434","article-title":"The combination of antidepressant drug therapy and high-frequency repetitive transcranial magnetic stimulation in medication-resistant depression.","volume":"22","author":"Bakim","year":"2012","journal-title":"Klinik Psikofarmakoloji B\u00fclteni-Bulletin of Clinical Psychopharmacology"},{"issue":"10","key":"zoi210753r32","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.4088\/JCP.09m05355gre","article-title":"A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.","volume":"72","author":"Barbee","year":"2011","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"zoi210753r33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1017\/S1092852900020216","article-title":"Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.","volume":"14","author":"Berman","year":"2009","journal-title":"CNS Spectr"},{"key":"zoi210753r34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fpsyt.2012.00074","article-title":"A randomized double-blind sham-controlled study of transcranial direct current stimulation for treatment-resistant major depression.","volume":"3","author":"Blumberger","year":"2012","journal-title":"Front Psychiatry"},{"issue":"6","key":"zoi210753r35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3109\/15622975.2011.579163","article-title":"A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression.","volume":"13","author":"Blumberger","year":"2012","journal-title":"World J Biol Psychiatry"},{"issue":"4","key":"zoi210753r36","doi-asserted-by":"publisher","first-page":"E58","DOI":"10.1503\/jpn.150265","article-title":"Unilateral and bilateral MRI-targeted repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled study.","volume":"41","author":"Blumberger","year":"2016","journal-title":"J Psychiatry Neurosci"},{"issue":"3","key":"zoi210753r37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0165-1781(02)00267-6","article-title":"Lack of a therapeutic effect of a 2-week sub-threshold transcranial magnetic stimulation course for treatment-resistant depression.","volume":"113","author":"Boutros","year":"2002","journal-title":"Psychiatry Res"},{"key":"zoi210753r38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2147\/NDT.S40466","article-title":"Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression.","volume":"9","author":"Chen","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"zoi210753r39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3109\/13651501.2015.1084329","article-title":"Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: a six-month clinical follow-up study.","volume":"19","author":"Concerto","year":"2015","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"4","key":"zoi210753r40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.biopsych.2014.11.023","article-title":"A randomized sham-controlled trial of deep brain stimulation of the ventral capsule\/ventral striatum for chronic treatment-resistant depression.","volume":"78","author":"Dougherty","year":"2015","journal-title":"Biol Psychiatry"},{"issue":"6","key":"zoi210753r41","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/YIC.0000000000000235","article-title":"Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial.","volume":"33","author":"Fava","year":"2018","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"zoi210753r42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jad.2012.02.017","article-title":"A double blind randomized trial of unilateral left and bilateral prefrontal cortex transcranial magnetic stimulation in treatment resistant major depression.","volume":"139","author":"Fitzgerald","year":"2012","journal-title":"J Affect Disord"},{"issue":"2-3","key":"zoi210753r43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0165-0327(00)00223-8","article-title":"Modest adjunctive benefit with transcranial magnetic stimulation in medication-resistant depression.","volume":"64","author":"Garcia-Toro","year":"2001","journal-title":"J Affect Disord"},{"issue":"3","key":"zoi210753r44","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1017\/S1461145712000910","article-title":"A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression.","volume":"16","author":"Heresco-Levy","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"zoi210753r45","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/03007995.2018.1430220","article-title":"Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study.","volume":"34","author":"Hobart","year":"2018","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"zoi210753r46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/(ISSN)1520-6394","article-title":"Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation.","volume":"19","author":"Holtzheimer","year":"2004","journal-title":"Depress Anxiety"},{"issue":"1","key":"zoi210753r47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/(ISSN)1520-6394","article-title":"Slow right prefrontal transcranial magnetic stimulation as a treatment for medication-resistant depression: a double-blind, placebo-controlled study.","volume":"19","author":"Kauffmann","year":"2004","journal-title":"Depress Anxiety"},{"issue":"Pt 7","key":"zoi210753r48","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1093\/brain\/awu109","article-title":"Efficacy of prefrontal theta-burst stimulation in refractory depression: a randomized sham-controlled study.","volume":"137","author":"Li","year":"2014","journal-title":"Brain"},{"issue":"2","key":"zoi210753r49","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/JCP.0b013e31816774f9","article-title":"The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.","volume":"28","author":"Marcus","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"zoi210753r50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S2215-0366(15)00436-8","article-title":"Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD Study): a double-blind, randomised, placebo-controlled trial.","volume":"3","author":"McAllister-Williams","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"zoi210753r51","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.neuroscience.2010.01.063","article-title":"Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression?","volume":"167","author":"Pallanti","year":"2010","journal-title":"Neuroscience"},{"issue":"3","key":"zoi210753r52","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4088\/PCC.v10n0302","article-title":"Efficacy and safety of antidepressant augmentation with lamotrigine in patients with treatment-resistant depression: a randomized, placebo-controlled, double-blind study.","volume":"10","author":"Santos","year":"2008","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"1","key":"zoi210753r53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1176\/appi.ajp.158.1.131","article-title":"A novel augmentation strategy for treating resistant major depression.","volume":"158","author":"Shelton","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"9","key":"zoi210753r54","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.4088\/JCP.14m09688","article-title":"Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants.","volume":"76","author":"Thase","year":"2015","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"zoi210753r55","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.4088\/JCP.14m09689","article-title":"Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study.","volume":"76","author":"Thase","year":"2015","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"zoi210753r56","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/YCT.0000000000000387","article-title":"Two versus one high-frequency repetitive transcranial magnetic stimulation session per day for treatment-resistant depression: a randomized sham-controlled trial.","volume":"33","author":"Theleritis","year":"2017","journal-title":"J ECT"},{"issue":"3","key":"zoi210753r57","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.psychres.2010.05.009","article-title":"Right and left dorsolateral pre-frontal rTMS treatment of refractory depression: a randomized, sham-controlled trial.","volume":"178","author":"Triggs","year":"2010","journal-title":"Psychiatry Res"},{"key":"zoi210753r58","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jad.2020.05.055","article-title":"A randomized controlled trial of a standard 4-week protocol of repetitive transcranial magnetic stimulation in severe treatment resistant depression.","volume":"274","author":"van Eijndhoven","year":"2020","journal-title":"J Affect Disord"},{"issue":"3","key":"zoi210753r59","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.brs.2011.08.005","article-title":"Transcranial direct current stimulation in treatment resistant depression: a randomized double-blind, placebo-controlled study.","volume":"5","author":"Palm","year":"2012","journal-title":"Brain Stimul"},{"issue":"7","key":"zoi210753r60","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.pnpbp.2010.06.009","article-title":"High-frequency rTMS treatment increases left prefrontal myo-inositol in young patients with treatment-resistant depression.","volume":"34","author":"Zheng","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"9","key":"zoi210753r61","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/jamapsychiatry.2018.1483","article-title":"Effect of repetitive transcranial magnetic stimulation on treatment-resistant major depression in US veterans: a randomized clinical trial.","volume":"75","author":"Yesavage","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"13","key":"zoi210753r62","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1038\/npp.2017.94","article-title":"Dose-related effects of adjunctive ketamine in Taiwanese patients with treatment-resistant depression.","volume":"42","author":"Su","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"zoi210753r63","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial.","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol Med"},{"issue":"1","key":"zoi210753r64","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/00004714-200302000-00013","article-title":"Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants.","volume":"23","author":"Nierenberg","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"zoi210753r65","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jad.2019.08.022","article-title":"Antidepressant and antisuicidal effects of ketamine on the functional connectivity of prefrontal cortex-related circuits in treatment-resistant depression: a double-blind, placebo-controlled, randomized, longitudinal resting fMRI study.","volume":"259","author":"Chen","year":"2019","journal-title":"J Affect Disord"},{"issue":"3","key":"zoi210753r66","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.jad.2013.07.035","article-title":"Aripiprazole augmentation to antidepressant therapy in Japanese patients with major depressive disorder: a randomized, double-blind, placebo-controlled study (ADMIRE study).","volume":"151","author":"Kamijima","year":"2013","journal-title":"J Affect Disord"},{"issue":"8","key":"zoi210753r67","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/pcn.2018.72.issue-8","article-title":"Randomized, double-blind comparison of aripiprazole\/sertraline combination and placebo\/sertraline combination in patients with major depressive disorder.","volume":"72","author":"Kamijima","year":"2018","journal-title":"Psychiatry Clin Neurosci"},{"key":"zoi210753r68","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jad.2018.09.037","article-title":"Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: a randomized, double blind, placebo controlled trial.","volume":"243","author":"Ionescu","year":"2019","journal-title":"J Affect Disord"},{"issue":"9","key":"zoi210753r69","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1177\/0269881117724352","article-title":"Minocycline as an adjunct for treatment-resistant depressive symptoms: a pilot randomised placebo-controlled trial.","volume":"31","author":"Husain","year":"2017","journal-title":"J Psychopharmacol"},{"issue":"11","key":"zoi210753r70","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S2215-0366(17)30371-1","article-title":"Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial.","volume":"4","author":"Holtzheimer","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"zoi210753r71","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m12058","article-title":"A randomized, placebo-controlled study of the efficacy and safety of fixed-dose brexpiprazole 2 mg\/d as adjunctive treatment of adults with major depressive disorder.","volume":"79","author":"Hobart","year":"2018","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"zoi210753r72","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/s41386-019-0369-9","article-title":"Superolateral medial forebrain bundle deep brain stimulation in major depression: a gateway trial.","volume":"44","author":"Coenen","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"zoi210753r73","doi-asserted-by":"publisher","first-page":"843","DOI":"10.4088\/JCP.v68n0604","article-title":"The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.","volume":"68","author":"Berman","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"zoi210753r74","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.clinph.2014.09.026","article-title":"Pilot study of feasibility of the effect of treatment with tDCS in patients suffering from treatment-resistant depression treated with escitalopram.","volume":"126","author":"Bennabi","year":"2015","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"zoi210753r75","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1017\/neu.2018.23","article-title":"A randomised, placebo-controlled 24-week study evaluating adjunctive brexpiprazole in patients with major depressive disorder.","volume":"31","author":"Bauer","year":"2019","journal-title":"Acta Neuropsychiatr"},{"issue":"1","key":"zoi210753r76","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pscychresns.2004.08.005","article-title":"High (20-Hz) and low (1-Hz) frequency transcranial magnetic stimulation as adjuvant treatment in medication-resistant depression.","volume":"146","author":"Garcia-Toro","year":"2006","journal-title":"Psychiatry Res"},{"issue":"1","key":"zoi210753r77","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/JCP.0000000000000245","article-title":"A randomized, double-blind, placebo-controlled phase 2 study of the augmentation of a nicotinic acetylcholine receptor partial agonist in depression: is there a relationship to leptin levels?","volume":"35","author":"Fava","year":"2015","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"zoi210753r78","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0165-1781(99)00092-X","article-title":"Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS.","volume":"88","author":"Padberg","year":"1999","journal-title":"Psychiatry Res"},{"issue":"5","key":"zoi210753r79","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.biopsych.2005.05.025","article-title":"Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.","volume":"58","author":"Rush","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"2","key":"zoi210753r80","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jad.2013.07.008","article-title":"Intensive HF-rTMS treatment in refractory medication-resistant unipolar depressed patients.","volume":"151","author":"Baeken","year":"2013","journal-title":"J Affect Disord"},{"issue":"1-3","key":"zoi210753r81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2009.01.029","article-title":"Meta-analysis of the placebo response in antidepressant trials.","volume":"118","author":"Rief","year":"2009","journal-title":"J Affect Disord"},{"issue":"1","key":"zoi210753r82","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/schbul\/sbx192","article-title":"Predictors of placebo response in pharmacological clinical trials of negative symptoms in schizophrenia: a meta-regression analysis.","volume":"45","author":"Fraguas","year":"2019","journal-title":"Schizophr Bull"},{"issue":"2","key":"zoi210753r83","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/YIC.0000000000000058","article-title":"Predictors of placebo response in bipolar depression.","volume":"30","author":"Nierenberg","year":"2015","journal-title":"Int Clin Psychopharmacol"},{"key":"zoi210753r84","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jad.2017.03.024","article-title":"Placebo and nocebo reactions in randomized trials of pharmacological treatments for persistent depressive disorder: a meta-regression analysis.","volume":"215","author":"Meister","year":"2017","journal-title":"J Affect Disord"},{"issue":"2","key":"zoi210753r85","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/wps.v16.2","article-title":"Has the rising placebo response impacted antidepressant clinical trial outcome? data from the US Food and Drug Administration, 1987-2013.","volume":"16","author":"Khan","year":"2017","journal-title":"World Psychiatry"},{"issue":"1","key":"zoi210753r86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/eb-2017-102827","article-title":"Is placebo response in antidepressant trials rising or not? a reanalysis of datasets to conclude this long-lasting controversy.","volume":"21","author":"Furukawa","year":"2018","journal-title":"Evid Based Ment Health"},{"issue":"9-10","key":"zoi210753r87","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s00508-020-01626-9","article-title":"Medical practice and placebo response: an inseparable bond?","volume":"132","author":"Jilch","year":"2020","journal-title":"Wien Klin Wochenschr"},{"issue":"5","key":"zoi210753r88","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/archgenpsychiatry.2010.46","article-title":"Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.","volume":"67","author":"George","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"zoi210753r89","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.biopsych.2007.01.018","article-title":"Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.","volume":"62","author":"O\u2019Reardon","year":"2007","journal-title":"Biol Psychiatry"},{"key":"zoi210753r24","volume-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor","year":"2015","edition":"12th ed"},{"key":"zoi210753r25","unstructured":"National Institute for Health and Care Excellence. Depression in adults: recognition and management. Published 2009. Accessed July 2, 2021. https:\/\/www.nice.org.uk\/guidance\/cg90"},{"key":"zoi210753r26","unstructured":"16.1.3.2 Imputing standard deviations for changes from baseline. Accessed April 5, 2021. https:\/\/handbook-5-1.cochrane.org\/chapter_16\/16_1_3_2_imputing_standard_deviations_for_changes_from_baseline.htm"},{"key":"zoi210753r29","unstructured":"StataCorp. Stata Statistical Software: Release 17. 2021. Accessed July 2, 2021. https:\/\/www.stata.com\/products\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2784479\/jones_2021_oi_210753_1640190723.94095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T11:00:37Z","timestamp":1640862037000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2784479"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":89,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.25531","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]}}}